Pharmacoeconomic analysis of various adjunctive pharmacotherapy strategies for back pain using comparative method
Spinal disorders are one of the leading causes of disability worldwide. Back pain is one of the most important factors that reduce the patients’ quality of life. The right choice of pharmacotherapy in conjunction with other medical technologies is the key to successful treatment. In addition to drugs that relieve pain, much attention should be paid to the restoration of cartilage in the spine. This paper presents a comparative pharmacoeconomic analysis of the use of chondroitin and glucosamine as the adjunctive therapy.